BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 38719255)

  • 1. Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion.
    Kramer S; van Hee K; Blokzijl H; van der Heide F; Visschedijk MC
    J Immunother; 2023 Sep; 46(7):271-275. PubMed ID: 37216403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab-Induced Pancreatic Exocrine Insufficiency Complicated by Severe Hepatic Steatosis.
    Hong AS; Sarwar N; Goldin RD; Dhar A; Possamai LA
    Cureus; 2022 Jul; 14(7):e26596. PubMed ID: 35936135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint inhibitor-associated celiac disease.
    Badran YR; Shih A; Leet D; Mooradian MJ; Coromilas A; Chen J; Kem M; Zheng H; Borowsky J; Misdraji J; Mino-Kenudson M; Dougan M
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
    Cheung VTF; Gupta T; Olsson-Brown A; Subramanian S; Sasson SC; Heseltine J; Fryer E; Collantes E; Sacco JJ; Pirmohamed M; Simmons A; Klenerman P; Tuthill M; Protheroe AS; Chitnis M; Fairfax BP; Payne MJ; Middleton MR; Brain O
    Br J Cancer; 2020 Jul; 123(2):207-215. PubMed ID: 32418993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion.
    Dong P; Xiong Y; Yue J; Hanley SJB; Watari H
    Front Oncol; 2018; 8():386. PubMed ID: 30283733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive bias in clinical medicine.
    O'Sullivan ED; Schofield SJ
    J R Coll Physicians Edinb; 2018 Sep; 48(3):225-232. PubMed ID: 30191910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition.
    Arasaradnam RP; Brown S; Forbes A; Fox MR; Hungin P; Kelman L; Major G; O'Connor M; Sanders DS; Sinha R; Smith SC; Thomas P; Walters JRF
    Gut; 2018 Aug; 67(8):1380-1399. PubMed ID: 29653941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated immune-related pancreatic exocrine insufficiency associated with pembrolizumab therapy.
    Prasanna T; McNeil CM; Nielsen T; Parkin D
    Immunotherapy; 2018 Mar; 10(3):171-175. PubMed ID: 29370723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.
    Barroso-Sousa R; Barry WT; Garrido-Castro AC; Hodi FS; Min L; Krop IE; Tolaney SM
    JAMA Oncol; 2018 Feb; 4(2):173-182. PubMed ID: 28973656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Haanen JBAG; Carbonnel F; Robert C; Kerr KM; Peters S; Larkin J; Jordan K;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv119-iv142. PubMed ID: 28881921
    [No Abstract]   [Full Text] [Related]  

  • 11. PD-1 and cancer: molecular mechanisms and polymorphisms.
    Salmaninejad A; Khoramshahi V; Azani A; Soltaninejad E; Aslani S; Zamani MR; Zal M; Nesaei A; Hosseini SM
    Immunogenetics; 2018 Feb; 70(2):73-86. PubMed ID: 28642997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Checkpoint Inhibitors: An Innovation in Immunotherapy for the Treatment and Management of Patients with Cancer.
    Dine J; Gordon R; Shames Y; Kasler MK; Barton-Burke M
    Asia Pac J Oncol Nurs; 2017; 4(2):127-135. PubMed ID: 28503645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrophic exocrine pancreatic insufficiency associated with anti-PD1 therapy.
    Hoadley A; Sandanayake N; Long GV
    Ann Oncol; 2017 Feb; 28(2):434-435. PubMed ID: 27864215
    [No Abstract]   [Full Text] [Related]  

  • 14. Pembrolizumab (Keytruda).
    Kwok G; Yau TC; Chiu JW; Tse E; Kwong YL
    Hum Vaccin Immunother; 2016 Nov; 12(11):2777-2789. PubMed ID: 27398650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitor associated diarrhoea.
    Al-Hussainy A; Adams J; Simmons J; Kennedy J
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38719255
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.